Post-acute COVID-19 syndrome and its prolonged effects : An updated systematic review
© 2022 The Authors..
Objective: This systematic review aimed at estimating the prevalence of post-acute COVID-19 symptoms in view of published literature that studied prolonged clinical manifestations after recovery from acute COVID-19 infection.
Methods: Relevant databases were searched for extraction of articles. For data synthesis, based on the distribution of quantitative variables, they were expressed as mean ± standard deviation (SD) or median and interquartile range (IQR). Qualitative variables were presented as frequency (n) and percentages (%).
Results: Twenty-one articles qualified for the final analysis. The most common persistent clinical manifestations were fatigue (54.11%), dyspnea (24.38%), alopecia (23.21%), hyperhidrosis (23.6%), insomnia (25.98%), anxiety (17.29%), and arthralgia (16.35%). In addition to these symptoms, new-onset hypertension, diabetes, neuropsychiatric disorders, and bladder incontinence were also reported.
Conclusion: Clinical features of post-acute COVID-19 infection can manifest even after 60 days of initial infection. Multidisciplinary care along with regular follow-up must be provided to such patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:80 |
|---|---|
| Enthalten in: |
Annals of medicine and surgery (2012) - 80(2022) vom: 28. Aug., Seite 103995 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Almas, Talal [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 27.08.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.amsu.2022.103995 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342430548 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342430548 | ||
| 003 | DE-627 | ||
| 005 | 20231226014110.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.amsu.2022.103995 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1141.xml |
| 035 | |a (DE-627)NLM342430548 | ||
| 035 | |a (NLM)35721785 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Almas, Talal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Post-acute COVID-19 syndrome and its prolonged effects |b An updated systematic review |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 The Authors. | ||
| 520 | |a Objective: This systematic review aimed at estimating the prevalence of post-acute COVID-19 symptoms in view of published literature that studied prolonged clinical manifestations after recovery from acute COVID-19 infection | ||
| 520 | |a Methods: Relevant databases were searched for extraction of articles. For data synthesis, based on the distribution of quantitative variables, they were expressed as mean ± standard deviation (SD) or median and interquartile range (IQR). Qualitative variables were presented as frequency (n) and percentages (%) | ||
| 520 | |a Results: Twenty-one articles qualified for the final analysis. The most common persistent clinical manifestations were fatigue (54.11%), dyspnea (24.38%), alopecia (23.21%), hyperhidrosis (23.6%), insomnia (25.98%), anxiety (17.29%), and arthralgia (16.35%). In addition to these symptoms, new-onset hypertension, diabetes, neuropsychiatric disorders, and bladder incontinence were also reported | ||
| 520 | |a Conclusion: Clinical features of post-acute COVID-19 infection can manifest even after 60 days of initial infection. Multidisciplinary care along with regular follow-up must be provided to such patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Long COVID | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Malik, Jahanzeb |e verfasserin |4 aut | |
| 700 | 1 | |a Alsubai, Abdulla K |e verfasserin |4 aut | |
| 700 | 1 | |a Jawad Zaidi, Syed Muhammad |e verfasserin |4 aut | |
| 700 | 1 | |a Iqbal, Raafe |e verfasserin |4 aut | |
| 700 | 1 | |a Khan, Kashif |e verfasserin |4 aut | |
| 700 | 1 | |a Ali, Muhammad |e verfasserin |4 aut | |
| 700 | 1 | |a Ishaq, Uzma |e verfasserin |4 aut | |
| 700 | 1 | |a Alsufyani, Majid |e verfasserin |4 aut | |
| 700 | 1 | |a Hadeed, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Alsufyani, Reema |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmed, Reema |e verfasserin |4 aut | |
| 700 | 1 | |a Thakur, Tushar |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Helen |e verfasserin |4 aut | |
| 700 | 1 | |a Antony, Meetty |e verfasserin |4 aut | |
| 700 | 1 | |a Antony, Ishan |e verfasserin |4 aut | |
| 700 | 1 | |a Bhullar, Anhad |e verfasserin |4 aut | |
| 700 | 1 | |a Kotait, Farida |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Ani, Lubabah |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of medicine and surgery (2012) |d 2012 |g 80(2022) vom: 28. Aug., Seite 103995 |w (DE-627)NLM245154396 |x 2049-0801 |7 nnns |
| 773 | 1 | 8 | |g volume:80 |g year:2022 |g day:28 |g month:08 |g pages:103995 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.amsu.2022.103995 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 80 |j 2022 |b 28 |c 08 |h 103995 | ||